Artefactum · Oct 8, 2026

PREMATURE OVARIAN INSUFFICIENCY: CARDIOMETABOLIC AND BONE REPERCUSSIONS AND IMPACT ON FERTILITY

By Martins AS, Marchese TC, Santos JM et al.

Premature ovarian insufficiency is defined by loss of ovarian activity before 40 years of age and combines reproductive impairment with prolonged exposure to hypoestrogenism. This narrative review aimed to critically synthesize evidence on cardiometabolic and skeletal repercussions of premature ovarian insufficiency and on its impact on fertility, emphasizing implications for longitudinal care. Searches were performed in 2026 in PubMed/MEDLINE and in official guideline sources from international reproductive medicine societies, prioritizing guidelines, systematic reviews, meta-analyses, clinical trials and observational studies directly addressing women with premature ovarian insufficiency. The evidence indicates an unfavorable cardiometabolic profile in part of this population, with alterations in lipid and glucose-related parameters and an increased long-term cardiovascular risk, although the magnitude of individual associations varies across studies. Bone health is consistently affected by prolonged estrogen deprivation, with lower bone mineral density and concern for future osteoporosis, supporting early hormone therapy and densitometric assessment. Fertility is markedly reduced but not invariably absent because intermittent ovarian activity may occur; no intervention has reliably restored natural conception rates, while oocyte donation remains an established reproductive option. Integrated management should therefore combine etiologic evaluation, appropriate hormone replacement, cardiometabolic surveillance, bone protection and individualized reproductive counseling.

doi.org/10.23900/artefactum.v25i10.4567Open accessInterventions

AgingResearch.News